Impaired FAO and mitochondrial overload can lead to acylcarnitine metabolic imbalances, disrupting insulin signaling through the regulation of mTOR phosphorylation and contributing to the onset and progression of IR and GDM 180. Here, INS is linked to gestational diabetes.